Fatal anaphylactic reaction due to ferric carboxymaltose: A case report

Fatal anaphylactic reaction due to ferric carboxymaltose: A case report

Bibliographic Details
Main Authors:	Aylin Mualla Arici, Zeynep Kumral, Ayşe Gelal, Bahri Akdeniz
Format:	Article
Language:	English
Published:	KARE Publishing 2020-07-01
Series:	Anatolian Journal of Cardiology
Subjects:	iron deficiency ferric carboxymaltose adverse drug reaction anaphylaxia pharmacovigilance
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-38996

Similar Items

Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
by: Wendy Fang, et al.
Published: (2019-10-01)

Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
by: Vineet Mishra, et al.
Published: (2018-01-01)

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study
by: I. E. Emrich, et al.
Published: (2020-07-01)

Efficacy and safety of intravenous ferric carboxymaltose in iron deficiency anemia; Real-life data from Turkey, a single center experience
by: Ali Eser, et al.
Published: (2021-06-01)

Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial
by: Ambily Jose, et al.
Published: (2019-02-01)

Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status
by: Wendy Fang, et al.
Published: (2020-06-01)

Short‐term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial‐IRON trial
by: Enrique Santas, et al.
Published: (2020-12-01)

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up
by: Antonio Lacquaniti, et al.
Published: (2020-09-01)

Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women
by: Jae-Yoon Shim, et al.
Published: (2018-08-01)

Hypophoshatemia Incidence in Patients with Chronic Kidney Disease Treated with Intravenous Ferric Carboxymaltose and Factors Related to Hypophosphatemia
by: Abdullah Şumnu, et al.
Published: (2020-09-01)

Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
by: Amreen Naqash, et al.
Published: (2018-01-01)

Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany
by: Froessler B, et al.
Published: (2018-04-01)

Intraoperative Anaphylactic Shock Due To Latex Allergy: Case Report
by: Mustafa Said Aydogan, et al.
Published: (2013-06-01)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
by: Jesse M. G. Hofman, et al.
Published: (2018-09-01)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
by: Adkinson NF, et al.
Published: (2017-09-01)

A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose
by: Giuseppe Rosano, et al.
Published: (2020-11-01)

Effectiveness of intravenous ferric carboxymaltose in improving hemoglobin level among postpartum women with moderate-to-severe anemia at a secondary care hospital in Faridabad, Haryana – An interventional study
by: Shashi Kant, et al.
Published: (2020-01-01)

Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis
by: Jamshed Dalal, et al.
Published: (2017-11-01)

The Effect of Intraoperative Ferric Carboxymaltose in Joint Arthroplasty Patients: A Randomized Trial
by: Hee-Sun Park, et al.
Published: (2019-10-01)

Evaluation of iron stores in hemodialysis patients on maintenance ferric Carboxymaltose dosing
by: Matthias Diebold, et al.
Published: (2019-03-01)

Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study
by: Roberto Minutolo, et al.
Published: (2021-03-01)

Ferric carboxymaltose solution versus iron sucrose complex in treating Iron-deficiency anemia patients with heavy uterine bleeding: A cost-efficacy study from a tertiary care hospital in the Kingdom of Saudi Arabia
by: Ayman Hejazi, et al.
Published: (2021-01-01)

The safety and efficacy of high dose ferric carboxymaltose in patients with chronic kidney disease: A single center study
by: S Vikrant, et al.
Published: (2015-01-01)

Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding
by: Raquel Ballester-Clau, et al.
Published: (2020-04-01)

Cardiovascular, liver, and renal toxicity associated with an intravenous ferric carboxymaltose similar versus the originator compound
by: Toblli JE, et al.
Published: (2017-11-01)

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Patients with Postoperative Anemia Following Same-Day Bilateral Total Knee Arthroplasty: A Randomized Controlled Trial
by: Man Soo Kim, et al.
Published: (2021-04-01)

Indirect comparison between ferric carboxymaltose and oral iron replacement in heart failure with reduced ejection fraction: a network meta-analysis
by: Edoardo Sciatti, et al.
Published: (2021-03-01)

Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project
by: Bernabeu-Wittel Máximo, et al.
Published: (2012-02-01)

IRON-DEFICIENCY ANEMIA IN PREGNANCY: PECULIARITIES OF THERAPY
by: M. A. Vinogradova
Published: (2018-01-01)

Effect of intravenous iron replacement therapy on exercise capacity in iron deficient anemic patients after cardiac surgery
by: Cinzia Nugara, et al.
Published: (2020-03-01)

Problem of iron-deficiency anemia in patients with cancers: practice in using iron-containing drugs
by: A V Snegovoy
Published: (2013-06-01)

Iron deficiency in heart failure
by: Goran Loncar, et al.
Published: (2021-08-01)

Effects of intravenous iron monotherapy for patients with iron deficient anemia undergoing total knee arthroplasty
by: Kyun-Ho Shin, et al.
Published: (2020-08-01)

Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis
by: Naser Yamani, et al.
Published: (2021-10-01)

A rare case of parental iron-induced persistent hypophosphatemia
by: Abigayle Sullivan, et al.
Published: (2020-03-01)

Clinical and biochemical features of some intravenous iron complexes
by: S. Yu. Abashin, et al.
Published: (2014-07-01)

Clinical and biochemical features of some intravenous iron complexes
by: S. Yu. Abashin, et al.
Published: (2014-07-01)

Role of intravenous iron in the treatment of anemia in patients with gastrointestinal tract tumors undergoing chemotherapy: a single-center, observational study
by: Lima J, et al.
Published: (2018-08-01)

Medical Case Report on Repeat Treatment of Restless Legs Syndrome with Intravenous Infusion of Iron
by: Katherine Condon, et al.
Published: (2021-09-01)

Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review
by: Xenophon Kassianides, et al.
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_a1de3egjgv2n39jp4get4fat1h